Résultats de la recherche - 1 result
Batch release of vaccines in Europe: from method transfer to first commercial batch available on the market. Straightforward approach that requires a proactive mind-set of the manufacturer.
is obligatory for vaccines (and blood/plasma-derived medicinal products), it is the company’s responsibility to choose an OMCL belonging to the OMCL network. This choice, which is free, should be made ...